Mechanisms of Soluble β-Amyloid Impairment of Endothelial Function
Open Access
- 1 November 2004
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 279 (46) , 48135-48142
- https://doi.org/10.1074/jbc.m407358200
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brainNature Medicine, 2003
- Compensatory Phosphorylation and Protein-Protein Interactions Revealed by Loss of Function and Gain of Function Mutants of Multiple Serine Phosphorylation Sites in Endothelial Nitric-oxide SynthaseJournal of Biological Chemistry, 2003
- β‐Amyloid inhibits NOS activity by subtracting NADPH availabilityThe FASEB Journal, 2002
- Alzheimer Disease as a Vascular DisorderStroke, 2002
- Intravascular infusions of soluble β-amyloid compromise the blood–brain barrier, activate CNS glial cells and induce peripheral hemorrhageBrain Research, 1999
- Cardiovascular factors in Alzheimer's diseaseJournal of Neurology, Neurosurgery & Psychiatry, 1998
- Cerebral vessels in ageing and Alzheimer's diseasePharmacology & Therapeutics, 1996
- Inhibition of Endothelial Nitric Oxide Synthase Activity by Protein Kinase CHypertension, 1995
- NITRIC OXIDE: A Physiologic Messenger MoleculeAnnual Review of Biochemistry, 1994
- Cellular hypertrophy in mesenteric resistance vessels from renal hypertensive rats.Hypertension, 1988